Molecular profiling of tumors at diagnosis.

Franco, Fernando; Carcereny, Enric; Guirado, Maria; Ortega, Ana L.; López-Castro, Rafael; Rodríguez-Abreu, Delvys; García-Campelo, Rosario; del Barco, Edel; Juan, Oscar; Aparisi, Francisco; González-Larriba, Jose L.; Domine, Manuel; Trigo, Jose M.; Cobo, Manuel; Cerezo, Sara; Calzas, Julia; Massutí, Bartomeu; Bosch-Barrera, Joaquim; Coves, Paola García; Domènech, Marta; Provencio, Mariano

doi:10.1371/journal.pone.0251761.s002

pone.0251761.s002.docx (17.97 kB)

Molecular profiling of tumors at diagnosis.

journal contribution

posted on 2021-06-02, 17:25 authored by Fernando Franco, Enric Carcereny, Maria Guirado, Ana L. Ortega, Rafael López-Castro, Delvys Rodríguez-Abreu, Rosario García-Campelo, Edel del Barco, Oscar Juan, Francisco Aparisi, Jose L. González-Larriba, Manuel Domine, Jose M. Trigo, Manuel Cobo, Sara Cerezo, Julia Calzas, Bartomeu Massutí, Joaquim Bosch-Barrera, Paola García Coves, Marta Domènech, Mariano Provencio

ALK, anaplastic lymphoma kinase; BRAF, B-RAF proto-oncogene, serine/threonine kinase oncogene; EGFR, epidermal growth factor receptor; FISH, fluorescence in situ hybridization; FGFR1, fibroblast growth factor receptor type 1; HER2, human epidermal growth factor receptor type 2; IHC, immunohistochemistry; KRAS, Kirsten rat sarcoma viral oncogene homolog; MET, tyrosine-protein kinase MET/hepatocyte growth factor receptor; PD-L1, programmed death-ligand 1; RET, proto-oncogene tyrosine-protein kinase receptor; RNA, ribonucleic acid; ROS1, ROS proto-oncogene 1 receptor tyrosine kinase; TTF1, thyroid transcription factor 1.

(DOCX)